IDEXX Laboratories, Inc. (VIE:IDXX)

Austria flag Austria · Delayed Price · Currency is EUR
552.20
+2.40 (0.44%)
Last updated: Oct 21, 2025, 3:30 PM CET
0.44%
Market Cap43.67B
Revenue (ttm)3.44B
Net Income (ttm)839.29M
Shares Outn/a
EPS (ttm)10.23
PE Ratio52.03
Forward PE47.62
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume1
Open552.80
Previous Close549.80
Day's Range552.20 - 554.20
52-Week Range322.60 - 598.20
Betan/a
RSI52.72
Earnings DateNov 3, 2025

About IDEXX Laboratories

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference... [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 1983
Employees 11,000
Stock Exchange Vienna Stock Exchange
Ticker Symbol IDXX
Full Company Profile

Financial Performance

In 2024, IDEXX Laboratories's revenue was $3.90 billion, an increase of 6.46% compared to the previous year's $3.66 billion. Earnings were $887.87 million, an increase of 5.07%.

Financial numbers in USD Financial Statements

News

There is no news available yet.